These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9588879)

  • 21. MCF10AT: a model for the evolution of cancer from proliferative breast disease.
    Dawson PJ; Wolman SR; Tait L; Heppner GH; Miller FR
    Am J Pathol; 1996 Jan; 148(1):313-9. PubMed ID: 8546221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of exposure of neonatal mice to 17beta-estradiol on subsequent age-incidence and morphology of carcinogen-induced mammary dysplasia.
    Warner MR; Warner RL
    J Natl Cancer Inst; 1975 Aug; 55(2):289-98. PubMed ID: 808639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs.
    Ferreira E; Gobbi H; Saraiva BS; Cassali GD
    Vet Pathol; 2012 Mar; 49(2):322-9. PubMed ID: 21282668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolactin and the development and progression of early neoplastic mammary gland lesions.
    Welsch CW
    Cancer Res; 1978 Nov; 38(11 Pt 2):4054-8. PubMed ID: 698954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions.
    Wellings SR; Jensen HM; Marcum RG
    J Natl Cancer Inst; 1975 Aug; 55(2):231-73. PubMed ID: 169369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.
    Namba R; Young LJ; Maglione JE; McGoldrick ET; Liu S; Wurz GT; DeGregorio MW; Borowsky AD; MacLeod CL; Cardiff RD; Gregg JP
    Breast Cancer Res; 2005; 7(6):R881-9. PubMed ID: 16280035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphology and progression of preneoplastic changes in methylcholanthrene-induced mouse mammary tumorigenesis.
    Basolo F; Fontanini G; Squartini F
    Tumori; 1985 Feb; 71(1):1-11. PubMed ID: 3984042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fine needle aspiration cytology diagnosis of ductal lesions of breast].
    Di F; Wong NL
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Usual hyperplasia, atypical hyperplasia and carcinoma-in-situ of breast: a morphologic study].
    Kan X; Shen DH; Shi B; He JS
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):312-5. PubMed ID: 15363313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of hyperplasia to cancer in 3-methylcholanthrene-induced mammary tumorogenesis.
    Fisher ER; Shoemaker RH; Sabnis A
    Lab Invest; 1975 Jul; 33(1):33-42. PubMed ID: 1142740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benign, preinvasive and invasive ductal breast lesions. A comparative study with quantitative techniques: morphometry, image- and flow cytometry.
    Ruiz A; Almenar S; Callaghan RC; Llombart-Bosch A
    Pathol Res Pract; 1999; 195(11):741-6. PubMed ID: 10605693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure.
    Murray TJ; Maffini MV; Ucci AA; Sonnenschein C; Soto AM
    Reprod Toxicol; 2007; 23(3):383-90. PubMed ID: 17123778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stages on the way to breast cancer.
    Going JJ
    J Pathol; 2003 Jan; 199(1):1-3. PubMed ID: 12474219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial hyperplasia and apoptosis following neonatal diethylstilbestrol exposure and subsequent estrogen stimulation in both host and transplanted hamster uteri.
    Hendry WJ; Zheng X; Leavitt WW; Branham WS; Sheehan DM
    Cancer Res; 1997 May; 57(10):1903-8. PubMed ID: 9157983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia.
    Brem SS; Gullino PM; Medina D
    Science; 1977 Mar; 195(4281):880-2. PubMed ID: 402692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nuclear localization of heterochromatic regions varies in hyperplastic and preneoplastic lesions of the breast].
    Arens N; Stiller M; Bierbaum M; Hildenbrand R
    Verh Dtsch Ges Pathol; 2005; 89():191-4. PubMed ID: 18035690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Atypical ductal and lobular hyperplasia of the breast].
    Bricou A; Delpech Y; Barranger E
    Gynecol Obstet Fertil; 2009 Oct; 37(10):814-9. PubMed ID: 19766043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orotic acid enhancement of preneoplastic and neoplastic lesions induced in the pancreas and liver of hamsters by N-nitroso(2-hydroxypropyl) (2-oxopropyl)amine.
    Kokkinakis DM; Albores-Saavedra J
    Cancer Res; 1994 Oct; 54(20):5324-32. PubMed ID: 7923160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.